Ventuno Biotech has secured a prêt d’amorçage investissement (PAI) from Bpifrance, in addition to the seed funding round completed last November. The financing represents a key milestone for Ventuno Biotech and strengthens the company’s resources to continue the development of its innovative immunotherapies.